Pacira BioSciences Inc (PCRX)
16.57
-0.03
(-0.18%)
USD |
NASDAQ |
Nov 01, 16:00
16.55
-0.02
(-0.12%)
After-Hours: 20:00
Pacira BioSciences Profit Margin (Quarterly): 10.61% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 10.61% |
| March 31, 2024 | 5.37% |
| December 31, 2023 | 13.72% |
| September 30, 2023 | 6.62% |
| June 30, 2023 | 15.20% |
| March 31, 2023 | -12.18% |
| December 31, 2022 | -5.87% |
| September 30, 2022 | -0.41% |
| June 30, 2022 | 11.73% |
| March 31, 2022 | 4.32% |
| December 31, 2021 | -3.22% |
| September 30, 2021 | 13.83% |
| June 30, 2021 | 14.07% |
| March 31, 2021 | 8.71% |
| December 31, 2020 | 11.08% |
| September 30, 2020 | |
| June 30, 2020 | -9.63% |
| March 31, 2020 | 7.72% |
| December 31, 2019 | -3.99% |
| September 30, 2019 | -5.81% |
| June 30, 2019 | 2.66% |
| March 31, 2019 | -3.03% |
| December 31, 2018 | 8.71% |
| September 30, 2018 | -0.77% |
| June 30, 2018 | 3.05% |
| Date | Value |
|---|---|
| March 31, 2018 | -14.32% |
| December 31, 2017 | 5.81% |
| September 30, 2017 | -11.28% |
| June 30, 2017 | -27.83% |
| March 31, 2017 | -28.67% |
| December 31, 2016 | -5.45% |
| September 30, 2016 | -32.42% |
| June 30, 2016 | -11.43% |
| March 31, 2016 | -5.89% |
| December 31, 2015 | -3.60% |
| September 30, 2015 | 4.96% |
| June 30, 2015 | 0.01% |
| March 31, 2015 | 2.16% |
| December 31, 2014 | 9.39% |
| September 30, 2014 | -5.77% |
| June 30, 2014 | -10.68% |
| March 31, 2014 | -31.30% |
| December 31, 2013 | -35.62% |
| September 30, 2013 | -63.56% |
| June 30, 2013 | -81.86% |
| March 31, 2013 | -199.7% |
| December 31, 2012 | -156.4% |
| September 30, 2012 | -185.5% |
| June 30, 2012 | -67.21% |
| March 31, 2012 | -152.4% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-12.18%
Minimum
Mar 2023
15.20%
Maximum
Jun 2023
4.87%
Average
7.17%
Median
Profit Margin (Quarterly) Benchmarks
| Cyclo Therapeutics Inc | -4.86K% |
| Revance Therapeutics Inc | -57.31% |
| NovaBay Pharmaceuticals Inc | -66.04% |
| Palatin Technologies Inc | -2.36K% |
| iBio Inc | -4.44K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 7.43% |
| Return on Assets | 4.03% |
| Return on Invested Capital | 4.55% |
| Gross Profit Margin (Quarterly) | 75.14% |
| Operating Margin (Quarterly) | 17.40% |
| Return on Net Operating Assets | 5.88% |